SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunomedics (IMMU) - moderated -- Ignore unavailable to you. Want to Upgrade?


To: erickerickson who wrote (62911)11/18/2024 3:29:33 PM
From: jhcimmu  Read Replies (2) | Respond to of 63305
 
Been an entrepreneur the past 6+ years. Left Pfizer in early 2018.

linkedin.com

What do people here feel would be a shareholder maximizing strategy for a product launch:

a) Partner with an existing global sales force

b) Build out an organic sales force

c) Sell the company to large bio

Without hiring, feels to me like Nassif would just be a filling a short term position.